Suzdak PD - Search Results

1

Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic.

Swedberg MD, Sheardown MJ, Sauerberg P, Olesen PH, Suzdak PD, Hansen KT, Bymaster FP, Ward JS, Mitch CH, Calligaro DO, Delapp NW, Shannon HE. Swedberg MD, et al. Among authors: suzdak pd. J Pharmacol Exp Ther. 1997 May;281(2):876-83. J Pharmacol Exp Ther. 1997. PMID: 9152397

2

M1 receptor agonist activity is not a requirement for muscarinic antinociception.

Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P. Sheardown MJ, et al. Among authors: suzdak pd. J Pharmacol Exp Ther. 1997 May;281(2):868-75. J Pharmacol Exp Ther. 1997. PMID: 9152396

3

Pharmacology of butylthio[2.2.2] (LY297802/NNC11-1053): a novel analgesic with mixed muscarinic receptor agonist and antagonist activity.

Shannon HE, Sheardown MJ, Bymaster FP, Calligaro DO, Delapp NW, Gidda J, Mitch CH, Sawyer BD, Stengel PW, Ward JS, Wong DT, Olesen PH, Suzdak PD, Sauerberg P, Swedberg MD. Shannon HE, et al. Among authors: suzdak pd. J Pharmacol Exp Ther. 1997 May;281(2):884-94. J Pharmacol Exp Ther. 1997. PMID: 9152398

4

Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogs.

Sauerberg P, Olesen PH, Sheardown MJ, Suzdak PD, Shannon HE, Bymaster FP, Calligaro DO, Mitch CH, Ward JS, Swedberg MD. Sauerberg P, et al. Among authors: suzdak pd. Life Sci. 1995;56(11-12):807-14. doi: 10.1016/0024-3205(95)00014-w. Life Sci. 1995. PMID: 10188779

5

Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.

Shannon HE, Bymaster FP, Calligaro DO, Greenwood B, Mitch CH, Sawyer BD, Ward JS, Wong DT, Olesen PH, Sheardown MJ, Swedberg MD, Suzdak PD, Sauerberg P. Shannon HE, et al. Among authors: suzdak pd. J Pharmacol Exp Ther. 1994 Apr;269(1):271-81. J Pharmacol Exp Ther. 1994. PMID: 7909557

6

Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).

Bymaster FP, Wong DT, Mitch CH, Ward JS, Calligaro DO, Schoepp DD, Shannon HE, Sheardown MJ, Olesen PH, Suzdak PD, Swedberg MD, Sauerberg P. Bymaster FP, et al. Among authors: suzdak pd. J Pharmacol Exp Ther. 1994 Apr;269(1):282-9. J Pharmacol Exp Ther. 1994. PMID: 7909558

7

Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.

Jackson HC, Hansen HC, Kristiansen M, Suzdak PD, Klitgaard H, Judge ME, Swedberg MD. Jackson HC, et al. Among authors: suzdak pd. Eur J Pharmacol. 1996 Jul 11;308(1):21-30. doi: 10.1016/0014-2999(96)00263-4. Eur J Pharmacol. 1996. PMID: 8836628

8

The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

Fink-Jensen A, Suzdak PD, Swedberg MD, Judge ME, Hansen L, Nielsen PG. Fink-Jensen A, et al. Among authors: suzdak pd. Eur J Pharmacol. 1992 Sep 22;220(2-3):197-201. doi: 10.1016/0014-2999(92)90748-s. Eur J Pharmacol. 1992. PMID: 1425991

9

Characterization of the metabotropic glutamate receptor in mouse cerebellar granule cells: lack of effect of 2,3-dihydroxy-6-nitro-7-sulphamoylbenzo(F)-quinoxaline (NBQX).

Suzdak PD, Sheardown MJ, Honoré T. Suzdak PD, et al. Eur J Pharmacol. 1993 May 15;245(3):215-20. doi: 10.1016/0922-4106(93)90099-u. Eur J Pharmacol. 1993. PMID: 7687559

10

AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h.

Sheardown MJ, Suzdak PD, Nordholm L. Sheardown MJ, et al. Among authors: suzdak pd. Eur J Pharmacol. 1993 Jun 4;236(3):347-53. doi: 10.1016/0014-2999(93)90470-3. Eur J Pharmacol. 1993. PMID: 7689464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters